Intra-aortic electrical counterpulsation

• US 9,005,106 B2
• Filed: 01/31/2008
• Issued: 04/14/2015
• Est. Priority Date: 01/31/2008
• Status: Active Grant

• Current Assignee: Enopace Biomedical Ltd.
• Original Assignee: Enopace Biomedical Ltd.
• Inventors: Gross, Yossi, Dagan, Amir
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): Dinga, Roland
• Application Number:
  US12/023,896
• Publication Number:
  US 20090198308A1
• Time in Patent Office: 2,630 Days
• Field of Search: 607/72, 600/18, 600/372, 600/373, 600/374, 600/508, 600/481
• US Class Current: 600/18
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36564 controlled by blood pressure

Abstract

In some embodiments of the present invention, apparatus is provided, including a sensing electrode configured to be implanted at a non-cardiac site in a vicinity of an aorta of a subject and to detect an electrical parameter of the aorta, and a control unit configured to receive the detected parameter and to generate an output in response to the detected parameter. Additional embodiments are also described.

Claims

1. Apparatus for use with a medical device, comprising:

a sensing electrode configured to be implanted at a non-cardiac site in a vicinity of an aorta of a subject and to detect an electrical parameter of the aorta; and

a control unit configured to;

receive the detected parameter,

extract first and second signal components from the detected parameter,

derive an ECG cycle of the subject, from the first component of the detected parameter,

derive a mechanical event within the aorta, from the second component of the detected parameter, and

in response to at least one derived parameter selected from the group consisting of;

the derived ECG cycle, and the derived mechanical event, control the medical device.

2. The apparatus according to claim 1, wherein the control unit is configured to be disposed in a vicinity of the subject'"'"'s aorta.

3. The apparatus according to claim 1, wherein the electrode comprises at least a first electrode and a second electrode, the first and second electrodes being configured to be placed within the aorta at a longitudinal distance from each other of between 10 mm and 30 mm.

4. The apparatus according to claim 1, wherein the control unit is configured to drive a current into the aorta in response to the detected parameter.

5. The apparatus according to claim 4, wherein the control unit is configured to detect a cardiac cycle of the subject, based upon the selected derived parameter, and is configured to drive the current in coordination with the subject'"'"'s cardiac cycle.

6. The apparatus according to claim 5, wherein the control unit is configured to dilate the aorta by increasing nitric oxide (NO) secretion by the wall of the aorta by applying the current.

7. The apparatus according to claim 6, wherein the control unit is configured, based upon the selected derived parameter, to detect systole of the subject, and wherein the control unit is configured to dilate the aorta in response to detecting systole of the subject.

8. The apparatus according to claim 6, wherein the control unit is configured to dilate the aorta by configuring the current to have a frequency of between 5 Hz and 20 Hz.

9. The apparatus according to claim 8, wherein the control unit is configured to dilate the aorta by configuring the current to have a frequency of between 10 Hz and 15 Hz.

10. The apparatus according to claim 6, wherein the control unit is configured to dilate the aorta by configuring the current to have an amplitude of between 1 mA and 5 mA.

11. The apparatus according to claim 10, wherein the control unit is configured to dilate the aorta by configuring the current to have an amplitude of between 2 mA and 3 mA.

12. The apparatus according to claim 5, wherein the control unit is configured, based upon the selected derived parameter, to detect diastole of the subject, and wherein the control unit, in response to detecting diastole of the subject, is configured to enhance constriction of the aorta by driving the current.

13. The apparatus according to claim 5, wherein the control unit,

is configured, based upon the selected derived parameter, to detect systole and diastole of the subject,

in response to detecting systole of the subject, is configured to dilate the aorta by increasing nitric oxide (NO) secretion by the wall of the aorta by driving the current, and

in response to detecting diastole of the subject, is configured to enhance constriction of the aorta by driving the current.